|
TBC1D15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.04720000448921E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.48690001924956E-09 |
| Normal-vs-Stage2 |
6.05080000000147E-05 |
| Normal-vs-Stage3 |
5.959100E-04 |
| Normal-vs-Stage4 |
2.350400E-02 |
| Stage1-vs-Stage2 |
6.203600E-01 |
| Stage1-vs-Stage3 |
3.542400E-01 |
| Stage1-vs-Stage4 |
8.764400E-01 |
| Stage2-vs-Stage3 |
7.491200E-01 |
| Stage2-vs-Stage4 |
8.352200E-01 |
| Stage3-vs-Stage4 |
6.719200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.09370001733345E-09 |
| Normal-vs-AfricanAmerican |
2.11009999999678E-05 |
| Normal-vs-Asian |
3.778700E-03 |
| Caucasian-vs-AfricanAmerican |
3.568200E-01 |
| Caucasian-vs-Asian |
8.594800E-01 |
| AfricanAmerican-vs-Asian |
5.979600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.67419983327011E-10 |
| Normal-vs-Female |
3.622200E-03 |
| Male-vs-Female |
7.572000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.581800E-04 |
| Normal-vs-Extreme_Weight |
4.46209735827097E-11 |
| Normal-vs-Obese |
1.410140E-04 |
| Normal-vs-Extreme_Obese |
2.11070000000202E-06 |
| Normal_Weight-vs-Extreme_Weight |
9.032200E-02 |
| Normal_Weight-vs-Obese |
6.241200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.508000E-01 |
| Extreme_Weight-vs-Obese |
1.227860E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.288200E-01 |
| Obese-vs-Extreme_Obese |
1.316000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.100640E-01 |
| Normal-vs-Age(41-60Yrs) |
1.34689999997661E-06 |
| Normal-vs-Age(61-80Yrs) |
6.8542005404737E-10 |
| Normal-vs-Age(81-100Yrs) |
9.7704999999948E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.719800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.842300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.712250E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.935700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.212800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.096000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.97420002357296E-10 |
| Normal-VS-Type2 PRCC |
1.64752999999296E-05 |
| Normal-VS-KIRP CIMP |
4.723800E-01 |
| Normal-VS-Unclassified PRCC |
4.556100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.282200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.703800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.135960E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.043200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.035800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.995400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.16990003532436E-09 |
| Normal-vs-N1 |
1.135780E-01 |
| Normal-vs-N2 |
1.207750E-02 |
| N0-vs-N1 |
1.794360E-02 |
| N0-vs-N2 |
6.582000E-01 |
| N1-vs-N2 |
5.272000E-01 |
|
|
